December 1, 2014

The Food and Drug Administration recently issued draft guidance on key product tracing provisions of the Drug Supply Chain Security Act, which is expected to be implemented by the industry on Jan. 1, 2015. 

December 1, 2014

Drug Store News will be tweeting key messages from retail pharmacy industry heavyweights.

December 1, 2014

Teva Pharmaceutical on Monday announced the launch of a generic version of Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) tablets in the United States. 

November 26, 2014

The American College of Emergency Physicians on Tuesday warned against overindulgence through the holidays in an effort to raise awareness around diabetes. 

November 25, 2014

Mylan on Tuesday confirmed that it — along with several subsidiaries — has been sued by Baxter International, Baxter Healthcare Corp. and Baxter Healthcare S.A. in relation to the filing of an abbreviated new drug application for the generic version of Brevibloc. 

November 24, 2014

American Well is among the first healthcare providers to see an uptick in online visits associated with influenza-like symptoms.

November 24, 2014

Dr. Reddy's Labs on Monday announced the launch of docetaxel injection USP in 20-mg and 80-mg dosage strengths. The drug is the generic version of Taxotere.

 

November 24, 2014

Omnicare and McKesson on Monday announced the signing of an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals. 

November 24, 2014

Perrigo on Monday announced that it has agreed to market the authorized generic version of Astellas U.S.' Protopic ointment 0.1% and 0.03%. 

November 21, 2014

A study being published in Annals of Internal Medicine suggests that people with atrial fibrillation who take NSAIDs may be at risk for serious bleeding or thromboembolisms. 

November 20, 2014

Amneal Pharmaceuticals on Thursday announced the launch of Lopreeza (estradiol/norethindrone acetate) tablets in 0.5-mg and 1-mg dosage strengths. The product is the first authorized generic of Activella from Novo Nordisk.

 

November 20, 2014

Decision Resources Group found that sales of biosimilar versions of the granulocyte colony-stimulating factors (G-CSFs) filgrastim and pegfilgrastim could reach $1.8 billion in the United States by 2023. 

November 20, 2014

Dr. Reddy’s Labs announced Thursday that it has launched a bioequivalent generic version of Allegra-D 12 Hour Allergy and Congestion, in the U.S. market.

November 20, 2014

The Generic Pharmaceutical Association on Thursday emphasized the savings generic medicines bring to the table in light of rising brand prices. 

November 20, 2014

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.

November 19, 2014

Nearly eight in 10 Americans (78%) would consider seeing a healthcare professional virtually for at least one healthcare need, according to a new Harris Poll.

November 19, 2014

The Food and Drug Administration opened a public docket and requested comments on proposed criteria for “first generic” abbreviated new drug application submissions.

 

November 18, 2014

Camber Pharmaceuticals on Monday announced their selection as a 2014 “Supplier of the Year” at Anda’s annual Supplier Strategy Meeting in Doral, Fla.

November 18, 2014

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries, on Tuesday announced that Health Canada has approved its application for PrTeva-Celecoxib, the generic equivalent of PrCelebrex.

November 17, 2014

A recent study by Field Agent examined what consumers are planning to do to keep themselves and their families healthy this fall.

November 17, 2014

DSN spoke with Neas in late October to mark the 30th anniversary of the landmark Drug Price Competition and Patent Term Restoration Act — better known as the Hatch-Waxman Act. 

November 17, 2014

Thirty years ago, Democratic and Republican members of Congress hammered out a rare and prescient bipartisan compromise bill that transformed the pharmaceutical landscape forever and unleashed the modern generic drug industry. That law, known as the Hatch-Waxman Act, has proven to be one of the most far-reaching and impactful pieces of legislation ever to shape the American healthcare system.

November 17, 2014

Pharmaceutical sales through HDMA-member traditional primary distributors reached nearly $305 billion in 2013.

November 17, 2014

Drug Store News caught up with Upsher-Smith chief commercial officer Rusty Field to discuss topiramate extended-release capsules, its new authorized generic to Qudexy XR.